Tensive to receive €20 million from EIB to commercialize bioresorbable breast implant

Milan, Italy – September 3, 2026 – Tensive S.r.l., a clinical-stage advanced biomaterials medical device company, and the developer of […]

Tensive reports pivotal 12-month clinical trial data confirming REGENERA™ delivers natural breast reconstruction after lumpectomy

Milan, Italy – July 28, 2026 – Tensive S.r.l., a clinical-stage advanced biomaterials medical device company, and the developer of […]

Tensive appoints Peter Crosby Chairman as its bioresorbable breast reconstruction scaffold approaches regulatory approval

Milan, Italy – July 8, 2026 – Tensive S.r.l., a clinical-stage advanced biomaterials medical device company, and the developer of […]

Tensive publishes positive interim pivotal clinical data showing REGENERA™ supports natural breast reconstruction in Updates in Surgery

Milan, Italy – April 15, 2026 – Tensive S.r.l., a clinical-stage advanced biomaterials medical device company developing REGENERA™ bioresorbable scaffolds […]

Independent study presented at ECR highlights REGENERA™ bioresorbable scaffold potential for breast restoration after lumpectomy

Milan, Italy – March 04, 2026 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™ bioresorbable scaffolds […]

Tensive reports positive pivotal trial top-line results showing REGENERA™ bioresorbable device may transform breast reconstruction

Milan, Italy – January 8, 2026 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing REGENERA™/SOFTAG™ bioresorbable scaffolds […]

Tensive publishes positive long-term clinical follow-up data in Breast Cancer on REGENERA™ / SOFTAG™ breast implant

Press release in italian Milan, Italy – 9 October, 2025 Tensive S.r.l, a clinical-stage advanced biomaterials medical device company developing […]

Tensive provides positive clinical updates highlighting potential of REGENERA™ / SOFTAG™ device to transform post-cancer breast reconstruction

Press release in italian Clinical data from two ongoing trials in patients undergoing lumpectomy confirm strong safety profile and growing […]

Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market

Press release in italian Has more than 30 years of experience bringing innovations to market, including one of the world’s […]

Tensive raises €14,000,000 Series A Financing Round led by Panakès Partners SGR to transform breast reconstruction following lumpectomy. Appoints Sanjay Kakkar as Chief Executive Officer

Platform based on innovative polymeric scaffolds applied as bio-absorbable implants Initially being developed in breast cancer reconstruction and breast augmentation […]